Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1995;26:1101-1106

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takagi, N.
Right arrow Articles by Takeo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takagi, N.
Right arrow Articles by Takeo, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE

(Stroke. 1995;26:1101-1106.)
© 1995 American Heart Association, Inc.


Articles

Changes in Striatal Dopamine Metabolism After Microsphere Embolism in Rats

Norio Takagi, MSc; Hironobu Tsuru, BSc; Motoko Yamamura, BSc Satoshi Takeo, PhD

From the Department of Pharmacology, Tokyo College of Pharmacy, Hachioji, Tokyo, Japan.

Correspondence to Satoshi Takeo, PhD, Department of Pharmacology, Tokyo College of Pharmacy, Hachioji, Tokyo 192-03, Japan.

Background and Purpose Dopamine plays an important role in striatal function. The present study was undertaken to elucidate the pathophysiological changes in striatal dopamine metabolism after microsphere embolism.

Methods Microspheres (48 µm) were injected into the right internal carotid artery of rats. Extracellular levels of dopamine and its metabolites were measured by in vivo microdialysis with the aid of high-performance liquid chromatography. In vivo striatal tyrosine hydroxylation and turnover (catabolism) rate of dopamine were estimated on the first and third days after the embolism. These were estimated by measuring tissue dopa or dopamine content in the presence of either an aromatic L-amino acid decarboxylase inhibitor or a tyrosine hydroxylase inhibitor, respectively.

Results In the microdialysis study, a 190-fold increase in the release of dopamine from the right striatum was observed 40 minutes after microsphere embolism, whereas the striatal dopamine metabolites decreased during the first 180 minutes after the embolism. Microsphere embolism decreased the striatal dopamine content throughout the experiment (28 days), whereas it increased tissue dopamine metabolites on the first day, followed by a decline in the metabolites on the third day or later. The in vivo turnover rate of dopamine decreased both on the first and third days, whereas the in vivo tyrosine hydroxylation decreased only on the third day after the embolism.

Conclusions The results suggest that microsphere embolism induces severe damage to striatal dopaminergic metabolism 3 to 28 days after the embolism. Dopamine synthesis may be more resistant to the embolism-induced ischemic insults than its catabolism.


Key Words: cerebral ischemia • embolism • dopamine • rats




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Sanbe, N. Takagi, Y. Fujiwara, J. Yamauchi, T. Endo, R. Mizutani, S. Takeo, G. Tsujimoto, and A. Tanoue
Alcohol preference in mice lacking the Avpr1a vasopressin receptor
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1482 - R1490.
[Abstract] [Full Text] [PDF]